• Home
  • Search
  • Alzheimer disease classification using KPCA, LDA, and multi‐kernel learning SVM
  • Cite Icon67
  • https://doi.org/10.1002/ima.22217Copy DOI Icon

Alzheimer disease classification using KPCA, LDA, and multi‐kernel learning SVM

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Abstract Early diagnosis of Alzheimer disease (AD) and mild cognitive impairment (MCI) is always useful. Preventive measures might have an impact on reducing AD risk factors. Structural magnetic resonance (MR) imaging, one of the vital sensitive biomarkers for cerebral atrophy in the brain, is used to extract volumetric feature by FreeSurfer and the CIVET toolbox. All of the structural magnetic resonance imaging (s‐MRI) data that we used were downloaded from the Alzheimer's disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu) of imaging data. This novel approach is applied for the diagnosis of AD and MCI from healthy controls (HCs) combining extracted features with the MMSE (mini‐mental state examination) scores, applying a two sample t‐test to select a subset of features. The subset of features is fed to kernel principal component analysis (KPCA) module to project data onto the reduced principal component coefficients at higher dimensional kernel space to increase the linear separability. Then, the kernel PCA coefficients are projected into the more efficient linear discriminant space using linear discriminant analysis. A multi‐kernel learning support vector machine (SVM) is used on newly projected data for stratification of AD and MCI from HCs. Using this approach, we obtain 93.85% classification accuracy when detecting AD from HCs for segmented volumetric features (using FreeSurfer) with high sensitivity and specificity. When distinguishing MCI from HCs and AD using volumetric features after subcortical segmentation, the detection rate reaches 86.54% and 75.12%, respectively.

Similar Papers
  • Peer Review Report

Decision letter: Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer’s disease continuum

  • May 13, 2022
  • Amy Kuceyeski
  • PDF
  • Research Article
  • Citations155

Prediction and Classification of Alzheimer’s Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers

  • Oct 16, 2019
  • Frontiers in Computational Neuroscience
  • Yubraj Gupta +2
  • Research Article
  • Citations184

Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry*

  • Dec 07, 2016
  • NeuroImage : Clinical
  • Lauge Sørensen +6
  • Research Article
  • Citations11

Ensemble of convolutional neural networks and multilayer perceptron for the diagnosis of mild cognitive impairment and Alzheimer's disease.

  • Oct 04, 2022
  • Medical Physics
  • Minglei Li +4
  • Research Article

Search for Clinical Markers Could? Transform Alzheimer's Drug Research

  • Jan 01, 2008
  • Caring for the Ages
  • Michele G Sullivan
  • Research Article
  • Citations39

Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative

  • Nov 02, 2012
  • Journal of Neurology, Neurosurgery & Psychiatry
  • Xiaowei Song +4
  • Conference Article
  • Citations139

DemNet: A Convolutional Neural Network for the detection of Alzheimer's Disease and Mild Cognitive Impairment

  • Nov 01, 2016
  • Ciprian D Billones +3
  • Front Matter
  • Citations14

Battle against Alzheimer's Disease: The Scope and Potential Value of Magnetic Resonance Imaging Biomarkers

  • Mar 28, 2012
  • Academic Radiology
  • Sophie Paquerault
  • PDF
  • Research Article
  • Citations64

Changes in Brain Lateralization in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Resting-State Functional Magnetic Resonance Study from Alzheimer's Disease Neuroimaging Initiative.

  • Feb 08, 2018
  • Frontiers in Neurology
  • Hao Liu +7
  • Research Article
  • Citations24

Latent diffusion model-based MRI superresolution enhances mild cognitive impairment prognostication and Alzheimer's disease classification

  • Jun 04, 2024
  • NeuroImage
  • Dan Yoon +6
  • Research Article
  • Citations32

Features of the superficial white matter as biomarkers for the detection of Alzheimer's disease and mild cognitive impairment: A diffusion tensor imaging study

  • Jan 01, 2022
  • Heliyon
  • Bahare Bigham +2
  • Research Article
  • Citations22

A Clinical Approach to Mild Cognitive Impairment

  • Nov 01, 2006
  • American Journal of Psychiatry
  • Paul B Rosenberg
  • PDF
  • Research Article
  • Citations6

The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer's Disease.

  • Sep 21, 2018
  • Frontiers in Aging Neuroscience
  • Chun-Chao Huang +5
  • Research Article
  • Citations28

Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study

  • Jan 01, 2018
  • Alzheimer's & Dementia: Translational Research & Clinical Interventions
  • Atsushi Iwata +12
  • Research Article
  • Citations608

Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults

  • Sep 07, 2015
  • BMC Geriatrics
  • Paula T Trzepacz +4
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.